QT Vascular Ltd.
QT Vascular is a Singapore-incorporated company focused on designing advanced therapeutic solutions for the treatment of complex vascular disease. QT Vascular is a global company engaged in the development and commercialization of innovative devices for the minimally invasive treatment of vascular disease without the use of permanent implants (stents). While stents deliver very important treatment benefits to many patients, they are also associated with the build up of scar tissue, metal fatigue leading to strut fracture , and the need for long-term blood thinning medications which can be expensive and have negative side effects. Treating a vessel without a permanent implant also allows the potential.
Company details
Find locations served, office locations
- Business Type:
- Manufacturer
- Industry Type:
- Medical Equipment
- Market Focus:
- Globally (various continents)
About us
QT Vascular is a global company that develops new and differentiated therapeutic solutions to address specific unmet clinical needs in the treatment of complex vascular disease.
TriReme Medical, a subsidiary of QT Vascular, manufactures and distributes the Chocolate and Glider families of angioplasty balloons.
History
TriReme Medical, Inc, TriReme Medical (Singapore) Pte, Ltd and Quattro Vascular Pte, Ltd are wholly-owned subsidiaries of QT Vascular Ltd and were co-founded by CEO Eitan Konstantino, Ph.D.
Incorporated in 2005, TriReme Medical initially developed the Antares, a dedicated stent for the treatment of bifurcations. Over time, TriReme developed and launched Glider™, GliderXtreme™ and GliderfleX®, all aimed at assisting physicians in the treatment of complex vascular lesions.
Quattro Vascular was incorporated in 2010 to support the development of Chocolate® – the first interventional medical device developed in Singapore to receive FDA approval.